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Purpose: Contractile activity of the trabecular meshwork (TM) and ciliary muscle (CM) influences aqueous humor
drainage; however, the mechanisms linking tissue contractility and regulation of aqueous humor drainage are not well
understood. Regulator of G Protein Signaling 2 (RGS2), a GTPase-activating protein of the Gαq family of proteins, plays
a critical role in regulation of contractile activity of vascular smooth muscle and in blood pressure homeostasis. To explore
a potential role for RGS2 in intraocular pressure (IOP) homeostasis, we evaluated RGS2 knockout (RGS2−/−) mice for
changes in IOP.
Methods:  IOP  was  measured  using  a  rebound  tonometer  in  awake  male  RGS2−/−  and  littermate  wild-type  mice.
Histological  and  immunofluorescence  analyses  were  performed  to  evaluate  changes  in  the  iridocorneal  structure,
actomyosin organization in CM and TM, and retinal ganglion cell survival in both central and peripheral retina.
Results: In repeated measurements, IOP was found to be consistently lower in the RGS2−/− mice compared to littermate
wild-type mice. This change in IOP appears to be associated with increased actin filament assembly in the CM, and
widening of the Schlemm’s canal in the aqueous humor drainage pathway. Furthermore, ganglion cell number in the
central retina was found to be significantly higher in the RGS2−/− mice relative to wild-type mice.
Conclusions: The data suggest that the deficiency of RGS2 decreased IOP, presumably due to increased aqueous humor
drainage in association with increased CM contraction. These data indicate a potentially critical role for RGS2 in
homeostasis of IOP and for retinal ganglion cell survival.
Glaucoma  is  a  major  cause  of  irreversible  blindness
worldwide.  Elevated  intraocular  pressure  (IOP)  due  to
impaired  aqueous  humor  drainage  can  cause  optic  nerve
damage  and  death  of  retinal  ganglion  cells,  leading  to
blindness  [1,2].  Therefore,  there  is  a  great  need  for
understanding the regulation of aqueous humor drainage and
finding the molecular targets for novel treatment of increased
IOP in glaucoma patients. IOP depends on a balance between
aqueous  humor  secretion  from  the  ciliary  body  (CB)
epithelium  and  aqueous  humor  outflow  in  the  trabecular
meshwork (TM) [1,3]. In open angle glaucoma patients, it is
generally believed that the production of aqueous humor is
not increased, but that drainage is impaired due to increased
resistance at a level in the outflow pathway close to the inner
wall of Schlemm’s canal (SC) [4]. Aqueous humor is drained
predominantly through conventional route, consisting of the
TM, juxtacanalicular area, and SC [4,5].
Cellular contraction and relaxation properties of both TM
and  ciliary  muscle  (CM)  have  been  reported  to  influence
aqueous humor outflow, and thus IOP [3,4,6]. Both TM and
CM  exhibit  smooth  muscle-like  properties  and  contain
functional  muscarinic,  α-adrenergic,  and  β-adrenergic
receptors [3,6]. Interestingly, the contractile status of TM and
CM has been demonstrated to exert antagonistic effects on
aqueous humor outflow, with contraction of the TM leading
to decreased aqueous humor outflow, and CM contraction
causing  increases  in  aqueous  humor  drainage  [3,4,6].
Moreover, several studies have demonstrated the influence of
the Rho GTPase/Rho kinase pathway, myosin II, myosin light
chain kinase, and actin polymerization on aqueous humor
drainage via the TM outflow pathway [4,7,8]. The Rho/Rho
kinase  pathway  regulates  smooth  muscle  contraction  in  a
calcium-independent manner via myosin II phosphorylation
[9].  Agonists  of  G-protein  coupled  receptors  (GPCR),
including angiotensin II, thromboxane A2, lysophosphatidic
acid,  endothelin-1,  and  thrombin,  induce  Rho  GTPase
activation and myosin light chain (MLC) phosphorylation in
TM cells. Perfusion with some of these agonists has been
observed to decrease aqueous humor outflow in enucleated
eyes [6,10,11], yet inhibition of Rho/Rho kinase and myosin
II  phosphorylation  in  the  trabecular  outflow  pathway
increases aqueous humor outflow [7]. Taken together, though,
these different observations strongly support a potential role
for several signaling mechanisms (e.g., GPCR and Rho/Rho
kinase-dependent  pathways)  in  the  regulation  of  aqueous
humor outflow, the role of these different signaling pathways
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Because  TM  and  CM  are  smooth  muscle-like,  we
hypothesized that regulator of G-protein signaling 2 (RGS2),
a regulatory protein that promotes vascular smooth muscle
relaxation  and  blood  pressure  homeostasis  [12-15],  might
control IOP. RGS2 is one of more than 20 RGS proteins that
regulate  signaling  via  GPCRs  in  part  by  accelerating  the
deactivation rates of Gα subunits via GTP hydrolysis [16,
17].  RGS2  preferentially  deactivates  Gαq  [18],  which
mediates  signaling  by  GPCRs  for  many  important
vasoconstrictors including angiotensin II, endothelin-1, and
vasopressin signal [19,20]. Activated Gαq in turn triggers
smooth muscle contraction via phospholipase C-induced Ca2+
release and subsequent increase in MLC phosphorylation by
calcium/calmodulin-dependent MLC kinase [21,22]. Gαq can
also trigger Rho GTPase signaling by certain Rho exchange
factors  [21,22].  Homozygous  deletion  of  RGS2  in  mice
increases blood pressure by impairing the ability of the nitric
oxide-cGMP pathway to promote vascular relaxation because
inhibition  of  vasoconstrictor-triggered  Gαq  signaling  is
abrogated [14,15].
To explore a potential role of RGS2 and Gαq-coupled
GPCR signaling in IOP homeostasis, we examined RGS2
knockout mice (RGS2−/−) for changes in IOP in this study.
Here we report decreased IOP and increased retinal ganglion
cell survival in RGS2−/− mice, possibly a result of increased
CM contraction.
METHODS
Animals: We used the well characterized homozygous RGS2
knockout (RGS2−/−) mouse strain along with the littermate
wild-type  mice  obtained  from  the  Blumer  laboratory,
Washington University School of Medicine, St. Louis, MO
[13].  The  genetic  background  of  this  mouse  strain  was
C57BL/6.  Polymerase  chain  reaction  (PCR)-based
genotyping  was  performed  using  tail  DNA  to  select  the
RGS2−/− mice. Male RGS2−/− mice 12 to 15 months old and
littermate wild-type mice were used in this study. All animal
procedures  were  conducted  in  accordance  with  the
Association  for  Research  in  Vision  and  Ophthalmology
(ARVO) statement for the use of animals in ophthalmic and
vision  research,  under  an  approved  Duke  University
institutional animal protocol. Animals were maintained under
a standard 12 h:12 h light-dark cycle. Food and water were
available ad libitum.
IOP  measurement:  IOP  was  measured  using  a  rebound
tonometer (Tiolat OY, Helsinki, Finland) according to the
manufacturer’s  protocol  and  as  described  by  Wang  et  al.
[23]. Briefly, the wild-type and RGS2−/− mice were gently
restrained in a clear, cone-shaped plastic bag with their heads
facing out, and they were tied to the flat plastic stand as
described by Wang et al. [23]. Prior to IOP measurements,
0.5%  proparacaine  anesthetic  solution  (Bausch  &  Lomb,
Tampa, FL) was applied to the eyes. IOP was measured in
both left and right eyes between 11 AM and 4 PM (12 h day
light cycle is from 7 AM to 7 PM), and each value was based
on an average of five independent tonometer readings. IOP
measurements were performed once a week for five weeks on
the  same  animals.  Changes  in  IOP  values  between  the
RGS2−/−  and  littermate  wild-type  mice  were  compared  at
weekly intervals as well as based on the average value of five
independent weekly measurements. IOP was expressed per
eye, and the sample number was 10 in each group.
Histology: The mice were euthanized with intraperitoneal
injection (150 mg/kg bodyweight) of sodium pentobarbital
solution  (obtained  from  Ovation  Pharmaceuticals,  Inc.,
Deerfield, IL) and followed by a heart puncture. Eyes were
enucleated  immediately  from  both  wild-type  and  RGS2−/−
mice  and  fixed  in  cold  0.1  M  cacodylate  buffer,  pH  7.3,
containing 2.5% glutaraldehyde for at least 2 h. Then the eyes
were dissected into anterior and posterior segments and rinsed
twice for 15 min with 0.1 M cacodylate buffer. These tissue
specimens  were  postfixed  in  0.1  M  cacodylate  buffer
containing 1% osmium tetroxide for 1.5 h at room temperature
and rinsed twice for 15 min with cacodylate buffer. The tissue
specimens were dehydrated with a series of ethanol (50 to
100%) and propylene oxide, and embedded with Spurr resin.
Next 0.8 µm sections, cut with a microtome, were stained with
1% methylene blue, and images were captured using a light
microscope (Zeiss Axioplan2, Carl Zeiss Microimaging, Inc.,
Thornwood, NY). The area and perimeter (total length) of SC
in  the  RGS2−/−  and  wild-type  mice  were  estimated  using
Metamorph  software  (Molecular  Devices,  Downingtown,
PA).
Immunohistochemistry: Freshly enucleated mouse eyes were
initially fixed in 4% paraformaldehyde at 4 °C for 1 h and then
dissected into anterior and posterior segments. These tissues
were further fixed in 4% paraformaldehyde for 2 h at 4 °C,
washed with phosphate buffered saline (PBS, consisting of
1.5 mM KH2PO4, 2.7 mM Na2HPO4, and 155 mM NaCl) and
cryoprotected in 5% sucrose overnight. The tissue specimens
were then shifted to 30% sucrose and incubated overnight
before embedding in Optimal Cutting Temperature compound
(Tissue-Tek obtained from Sakura Finetek, Torrance, CA)
and cryosectioning by cryotome (Microm HM550, Microm,
Germany). The tissue cryosections derived from the anterior
segment (8 µm) and posterior segment (10 µm) were air dried,
washed three times in PBS, and incubated with Image-iT FX
Signal Enhancer (Molecular Probes, Eugene, OR) for 30 min.
The  anterior  sections  were  washed  three  times  in  PBS
containing 0.3% Triton X-100 for 2 min, and blocked with 3%
fetal bovine serum for 2 h at 4 °C. The blocked sections were
incubated with phalloidin conjugated with tetra rhodamine
isothiocyanate (Sigma-Aldrich, St. Louis, MO) for 20 min at
room temperature. Retinal sections (posterior segments) for
ganglion cell staining were washed three times in PBS for 2
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a wash with PBS, the sections were blocked with 10% donkey
serum for 2 h at 4 °C and incubated overnight at 4 °C with
1:25 dilution polyclonal Brn-3 primary antibody, which is
known to react with Brn-3a, Brn-3b, and Brn-3c subtypes
(Cat. No. Sc-6026; Santa Cruz Biotechnology, Santa Cruz,
CA). After three 5 min washes with PBS, the specimens were
incubated  with  a  1:100  dilution  anti-goat  IgG  coupled  to
Alexa-594 (Molecular Probes) for 2 h at room temperature.
The tissue sections were washed with PBS for 5 min and co-
stained with Hoechst 33258 (Invitrogen, Carlsbad, CA) for 15
min. Slides were mounted with Fluoromount-G (Southern
Biotech,  Birmingham,  AL).  Fluorescence  images  were
captured  using  a  Nikon  EclipseC90i  microscope  (Nikon,
Tokyo, Japan) and analyzed with Metamorph software.
Retinal ganglion cell counting: Three retinal cryosections per
eye were fixed on each slide, and four slides per eye, from
both wild-type and RGS2−/− mice, were immunostained for
Brn-3, a marker of ganglion cells, as described in the previous
section.  Four  individual  tissue  sections  were  counted  for
Brn-3 positive cells. Brn-3 positive cells and the total number
of nuclei in the ganglion cell layer of the retina based on
Hoechst staining were counted manually per 750 μm of retina,
and the values of four independent sections of the same eye
were averaged. These cell counts were performed for the
central and peripheral retina, and differences in the cell count
between the wild-type and RGS2−/− mice were determined.
Cell culture: To confirm the expression of RGS2 and Gαq in
TM and CB cells, we isolated human TM and human CB cells
from human donor eyes by digesting the TM tissue with Type
IV collagenase as described previously [24]. The cells were
cultured in Dulbecco’s Modified Eagle Medium with 10%
fetal  bovine  serum,  100  U/ml  penicillin,  and  100  μg/ml
streptomycin at 37 °C under 5% CO2.
Reverse  transcriptase-polymerase  chain  reaction:  Reverse
transcriptase-polymerase chain reaction (RT–PCR) analysis
was performed on RGS2 and Gαq. Both human TM and CB
cells were grown to confluence, and total RNA was extracted
using the Rneasy Micro kit (Qiagen, Valencia, CA) according
to the manufacturer’s instructions. Total RNA was used for
reverse  transcription,  which  was  performed  with  the
Advantage®  RT-for-PCR  kit  (Clontech,  Mountain  View,
CA). PCR amplification was performed using the Choice-
TaqTM DNA polymerase kit (Denville Scientific, Metuchen,
NJ) and the following gene-specific oligonucleotide primers:
RGS2: (5′-GGC TGC TTT ACA ACT GCC AGA A-3′/5′-
GTT TCC TGA ACA CCC AGG CTG AA-3′) and Gαq: (5′-
CCC TGC CTA CCT GCC TAC GCA ACA A-3′/5′-TGT
GGC  GCA  CGT  GAA  GTG  GGA  GTA  G-3′).  Controls
having no RT were included. Prior to RT reactions, total RNA
was treated with DNase-1 to eliminate DNA contamination.
Statistical analysis: Results were presented as the mean plus
or minus standard error (SEM), and statistical significance
was evaluated by the Student’s t test. A value of p<0.05 was
considered significant.
RESULTS
To determine the effects of RGS2, a negative regulator of
Gαq on IOP homeostasis, we monitored IOP changes in mice
with  homozygous  deletion  of  RGS2,  using  a  rebound
tonometer. These measurements were performed in conscious
12- to 15-month-old mice. IOP was recorded five times on the
same  animals  (both  wild-type  and  RGS2−/−)  at  a  weekly
interval.  The  order  of  IOP  measurements  between  the
RGS2−/− and wild-type mice was random.
IOP, based on average values of 10 eyes (both left and
right), was found to be consistently lower in the RGS2−/− mice
compared to the littermate wild-type mice measured over five
independent occasions (Figure 1A-E). While the average IOP
in wild-type mice was found to be above 20 mmHg (ranging
from 18 to 25 mmHg), it was below 18 mmHg (ranging from
14 to 20 mmHg) in the RGS2−/− mice. Additionally, based on
the average values of IOP derived from five independent
measurements (Figure 1F), IOP was found to be significantly
(p<0.05)  lower  in  the  RGS2−/−  mice  (17.98±1.34  mmHg)
compared to the wild-type mice (21.39±2.88 mmHg).
To gain insight into the IOP changes in the RGS2−/− mice
(Figure 1), we performed histologic studies of the iridocorneal
angle structure. Figure 2 illustrates the iridocorneal structure
of  the  RGS2−/−  and  wild-type  mice.  While  there  were  no
obvious differences between the RGS2−/− and wild-type mice
in the iridocorneal structure (including TM and CB; Figure
2A), the SC area was found to be 80% larger in the RGS2−/−
mice compared to the wild-type mice (based on Metamorph
analysis; n=6; Figure 2B). The difference in perimeter (the
total length or circumference) of SC between the RGS2−/− and
wild-type mice, however, was not significant. The thickness
of sclera (in μm) over the aqueous humor drainage angle in
the RGS2−/− mice appears to be marginally thinner (78.0±6.8)
than  in  the  wild-type  mice  (90.7±22.4);  however,  the
difference was not found to be significant (p<0.6) between the
two groups of mice. The values are based on six samples and
expressed as mean±SEM.
To obtain further insight into the observed increase in SC
area in the RGS2−/− mice, we evaluated possible changes in
the actin cytoskeletal organization of the iridocorneal angle.
The iridocorneal cryosections derived from the RGS2−/− and
wild-type  mice  were  stained  for  actin  filaments  with
rhodamine phalloidin, and the distribution of actin filaments
in the iridocorneal angle was recorded using a fluorescence
microscope. Interestingly, the specimens of the RGS2−/− mice
revealed increased actin filament staining in the CM and TM
areas with relatively stronger staining in the CM as compared
to the wild-type specimens. Representative images derived
from two independent RGS2−/− (Figure 3C,D) and wild-type
(Figure  3A,B)  mice  are  shown  in  Figure  3.  Figure  3E-H
Molecular Vision 2009; 15:495-504 <http://www.molvis.org/molvis/v15/a50> © 2009 Molecular Vision
497illustrates the images taken under bright-field of the same
sections stained for the actin filament (Figure 3A-D). The
results represent the observations based on four independent
specimens. The increased actin filament staining in the CM
and  TM  indicates  induced  actomyosin  assembly  and
contraction, perhaps due to augmented Gαq-dependent GPCR
signaling in the RGS2−/− mice.
Primary  cultures  of  human  CB  and  TM  cells  were
confirmed to express both RGS2 and Gαq based on RT–PCR
analysis  (data  not  shown).  Elevated  IOP  from  impaired
aqueous  humor  drainage  has  been  well  recognized  to
influence the survival status of retinal ganglion cells [25,26].
Therefore,  the  RGS2−/−  mice  that  showed  a  significant
decrease in IOP compared with wild-type mice (Figure 1F)
were evaluated for changes in retinal ganglion cell count.
Since glaucoma is an age-related disease, we used 12- to 15-
month-old RGS2−/− and wild-type mice to evaluate the chronic
effects of RGS2 deficiency on retinal ganglion cell count
using  tissue  cryosections  derived  from  the  central  and
peripheral  retina.  The  retinal  tissue  cryosections  were
immunolabeled for Brn-3 (red staining), a well characterized
Pit-Oct-Unc  (POU)  domain  protein  and  extensively  used
ganglion cell marker [27]. The same tissue specimens were
also labeled with Hoechst (blue staining) to count the total
number  of  cells.  Both  the  Brn-3-positive  cells  and  total
number of nuclei (Hoechst positive) were manually calculated
for the same region and expressed per unit area of the retina.
Figure 4A-F shows representative fluorescence images
of  Brn-3-positive  cells  and  Hoechst-positive  cells  derived
from the RGS2−/− and wild-type mice, as well as superimposed
images of the Brn-3 and Hoechst labeling. The number of
Brn-3-positive cells in the ganglion cell region of the central
retina was found to be significantly higher (20% higher than
corresponding controls; p<0.05) in the RGS2−/− mice than in
the  wild-type  mice  (Figure  4G).  In  the  peripheral  retina,
however, there was no difference in the Brn-3 positive cells
between the two groups of mice. The total number of cell
nuclei in the ganglion cell region of the central retina was
found to be marginally higher in the RGS2−/− mice but not
significantly different from the wild-type mice (Figure 4H).
The increased Brn-3-positive cells in the ganglion cell layer
of the central retina indicates increased retinal ganglion cell
survival in the RGS2−/− mice compared to the littermate wild-
type mice.
DISCUSSION
IOP homeostasis is critically important for both the health of
the optic nerve head and retinal ganglion cell survival, and
ultimately for normal vision. Increased IOP linked to impaired
aqueous humor drainage has been considered a major risk
factor  for  glaucoma  [1].  Although  various  agonists  and
antagonists of GPCRs have been documented to influence
aqueous humor outflow and IOP, very little is known about
the  identity  of  predominant  GPCR  signaling  pathways
Figure 1. Intraocular pressure changes
in the RGS2−/− mice. Diurnal IOP was
measured in both right and left eyes in
conscious  animals,  using  a  rebound
tonometer.  Measurements  were
performed  five  times  on  the  same
animals at weekly intervals A-E: IOP
changes  in  the  RGS2−/−  mice  were
compared with those of wild-type (WT)
mice recorded over five different days.
F: IOP changes between the wild-type
and RGS2−/− mice, based on the average
of five independent measurements, are
shown  in  panel  A-E.  Each  error  bar
represents  the  mean±SEM  (n=8–10
eyes). Asterisk represents p<0 0.05.
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498regulating  aqueous  humor  outflow  and  IOP  [3,4,6,10,11,
28-30]. To explore the involvement of Gαq-coupled GPCR
signaling in IOP homeostasis, we evaluated IOP changes in
RGS2 null mice (RGS2−/−) in this study. Gαq is a GPCR-
coupled G-protein that stimulates the contractile activity of
smooth muscle [21,22]. RGS2 serves as a negative regulator
of  Gαq  by  accelerating  its  GTPase  activity  and  thereby
terminating the signal response of Gαq [16,17]. RGS2−/− mice
showed a decrease in IOP in repeated measurements, and this
effect appeared to be associated with an increase in the width
of the SC, likely due to increased actomyosin assembly and
the  resultant  increase  in  tissue  contractility  in  the  ciliary
muscle.
The mean value of diurnal IOP in the RGS2−/− mice was
found  to  be  17.98±1.34  mmHg  compared  to
21.39±2.88 mmHg in littermate wild-type mice. Based on
several published reports on the rodent glaucoma model, the
difference of roughly 3.4 mmHg IOP observed in the RGS2−/
−  mice  is  considered  to  be  physiologically  significant
[31-33]. Moreover, this decreased IOP in the RGS2−/− mice is
likely  a  chronic  response  stemming  from  the  deletion  of
RGS2. In this study, the nocturnal IOP was not monitored;
however, since nocturnal IOP is higher relative to the diurnal/
sleep period in rodents [32,34], it is possible that the lowered
IOP (diurnal) observed in RGS2−/− mice is indicative of a
much more significant drop in the IOP associated with the
nocturnal period.
Interestingly, the lowered IOP in the RGS2−/− mice was
found to be associated with an increase in the SC area, owing
to a widening of the SC. Although the specific mechanisms
responsible  for  the  observed  widening  of  the  SC  in  the
RGS2−/−  mice  are  not  known  (Figure  2),  this  observation
suggests a possible mechanical deformation of SC. Agonists,
such as pilocarpine and other miotics, have been shown to
cause mechanical deformation of TM and SC due to increased
CM  contraction,  resulting  in  increased  aqueous  humor
outflow and decreased IOP [5,6,35]. The tendons arising from
the anterior tips of the ciliary muscle insert into the TM and
well into the subendothelial region adjacent to the inner wall
of the SC [36]. Due to this intimate anatomic relationship
between the TM and the CM, when CM contraction is induced
by pilocarpine and other miotics, it has been shown to cause
TM  expansion  and  widening  of  the  SC  and  ultimately
decreasing  outflow  resistance  [35-37].  The  muscarinic
receptors (M1 and M3) that are coupled to Gαq have been
reported to be expressed in the CM and TM [6,28,30,38-40].
Therefore, we speculate that the increased SC area in the
RGS2−/− mice might potentially be due to altered geometry of
the aqueous outflow pathway in response to increased CM
contraction. For SC morphology we used six individual eyes
from each group (RGS2−/− and control), and these animals
were euthanized in three different batches on different days.
We saw distinct and consistent changes in the RGS2 −/− mice
as compared to wild-type mice, thus it is unlikely that these
observations represent the result of fixation artifact.
Figure 2. Iridocorneal histological changes in the RGS2−/− mice. A: Iridocorneal histological analysis was performed to examine structural
differences in the aqueous humor outflow pathway and ciliary body between the RGS2−/− and wild-type mice. The structural integrity of the
trabecular meshwork (TM), ciliary body (CB), and ciliary muscle (CM) were found to be comparable between the two groups of mice. However,
the Schlemm’s canal (SC) area was found to be significantly larger in the RGS2−/− mice compared to the littermate wild-type mice. B:
Quantitative changes in the SC area between the RGS2−/− and wild-type mice based on Metamorph pixel analysis. Values are shown as mean
±SEM (n=6). Asterisk represents p<0.05. Abbreviations: sclera (SCL), retina (RT).
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499In support of the hypothesis of increased contraction of
the CM in RGS2−/− mice, we also noted an increased staining
for actin filaments in the CM, indicating induced contractile
actomyosin  assembly.  The  TM  tissue  also  exhibited  an
increase  in  actin  filament  assembly  based  on  phalloidin
staining;  however,  F-actin  staining  in  the  CM  was  much
higher relative to that noted in the TM (Figure 3). Increased
myosin II phosphorylation via sustained activation of Gαq
signaling  in  the  RGS2−/−  mice  was  expected  to  induce
actomyosin assembly, leading to enhanced contraction [22,
41], and our results of increased actin filament staining in the
CM of RGS2−/− mice supported this possibility. Additionally,
impaired nitric oxide-cGMP mediated relaxation which is
known to occur in RGS2−/− mice might also have contributed
significantly  to  observed  increase  in  CM  actomyosin
assembly [12,14,15,42-44]. Though additional biochemical
studies are necessary to support this contention, the RGS2−/−
mice have been reported to develop systemic hypertension
due to impaired vascular smooth muscle relaxation [12,13,
15,42]. Moreover, it has been reported that the expression and
regulation of RGS2 activity plays a critical role in regulation
of  vascular  endothelial  contraction  and  blood  pressure
homeostasis [45]. Therefore, changes in RGS2 expression in
the outflow pathway and ciliary body might also influence
IOP.
IOP values obtained in this study were noted to be slightly
higher than reported values for the mouse species [23,46],
This discrepancy might have stemmed from the lack of use of
general anesthesia in this study. The use of anesthetics has
been shown to lower IOP significantly [23,47]. However, it
also important to note that, unlike the studies reported by
Wang et al. [23], the rebound tonometer was not steadied and
fixed during the course of acquiring IOP measurements in our
studies. Since agitation of mice has been shown to cause
elevated IOP [23], any stress or agitation caused by routine
physical handling might also be a contributory factor in the
higher IOP values obtained in our study.
Both RGS2 and Gαq were confirmed to be expressed in
the  TM  and  CM  tissues,  however,  regulation  of  RGS2
expression in these tissues is not known. Importantly, RGS2
expression  has  been  shown  to  be  influenced  by  various
pharmacological and physiologic agents in different tissues
[48-51].  Therefore,  in  future  studies,  analysis  of  RGS2
expression in the CM and TM tissues of glaucomatous and
age-matched normal eyes might provide significant insight
into the role of RGS2 in the pathophysiology of glaucoma.
Since IOP is determined by the balance between aqueous
Figure 3. Changes in actin filament staining at the iridocorneal angle of the RGS2−/− mice. Cryosections of the eye anterior chamber including
the iridocorneal region derived from the RGS2−/− and wild-type mice were labeled for filamentous actin with rhodamin-phalloidin, and
fluorescence images were recorded. Actin filament staining (bright red fluorescence) in the ciliary muscle (CM) and trabecular meshwork
(TM) of the RGS2−/− mice (C and D) was found to be more intense relative to the wild-type mice (A and B), with much stronger staining in
the ciliary body (CB) as opposed to the TM. Panels E-H show images of the same specimens stained for the actin filaments (A-D), but recorded
under bright-field settings. Abbreviations: retina (RT); Schlemm’s canal (SC); sclera (SCL). Scale bar represents 50 µm.
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500outflow and inflow [3], it is also necessary to exercise caution
while interpreting the results of lowered IOP in RGS2 −/− mice,
particularly with regard to whether this response is solely due
to increased aqueous outflow through the TM or also partly
owing to decreased secretion of aqueous humor by the ciliary
epithelium.  Episcleral  venous  pressure  is  recognized  to
potentially influence IOP [52]. However, we did not monitor
changes in episcleral venous pressure in the RGS2−/− mice.
Thus, it remains to be determined whether there was any
influence  of  episcleral  venous  pressure  on  the  observed
changes in IOP in the RGS2−/− mice.
Since elevated IOP has been shown to influence retinal
ganglion  cell  survival  [25,26,53,54],  we  also  evaluated
changes in the retinal ganglion cell count in the RGS2−/− mice
by immunofluorescence analysis using Brn-3 antibody. The
ganglion  cell  count  in  the  central  retina  was  found  to  be
Figure 4. Increased retinal ganglion cell
survival  in  the  RGS2−/−  mice.  To
determine the effect of RGS2 on retinal
ganglion cell survival in the RGS2−/−
mice,  we  used  retinal  cryosections
derived from 12 to 15-month old male
mice and immunolabeled ganglion cells
with Brn-3-specific antibody. The same
specimens  were  also  stained  with
Hoechst 33258 dye to count the total
number  of  cells  in  the  ganglion  cell
region.  Panels  A  and  B  show  Brn-3-
specific immunostaining (red), C and D
show Hoechst staining (blue), and E and
F depict the overlapping of Brn-3 and
Hoechst  staining.  G:  Quantitative
changes  in  the  Brn-3-positive  retinal
ganglion  cells  between  the  RGS2−/−
and  wild-type  mice.  H:  Quantitative
changes in the total number of cells in
the ganglion cell region of the retina in
RGS2−/−  and  wild-type  mice.  The
RGS2−/−  mice  show  a  significant
increase in Brn-3-positive cells in the
ganglion cell region of the central retina
as compared to the wild-type mice. The
total number of cells in the ganglion cell
region  of  the  central  retina  based  on
Hoechst  staining  did  not  show
significant  difference  between  two
groups  of  the  mice.  Cell  number  is
expressed per unit area, and values are
expressed  as  mean±SEM  (n=4).  The
asterisk  indicates  a  p<0.05.
Abbreviations:  ganglion  cell  layer
(GCL);  inner  plexiform  layer  (IPL);
inner  nuclear  layer  563  (INL);  outer
nuclear  layer  (ONL);  outer  plexiform
layer (OPL). Scale bar represents 100
μm.
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501significantly higher in the RGS2−/− mice compared to the
littermate wild-type mice. One plausible explanation for the
increased ganglion cell survival in the RGS2−/− mice may
relate to the decreased IOP in these mice. The RGS2 −/− mice
used in this study were 12 to 15 months of age, and aging alone
decreases retinal ganglion cell survival [55]. Moreover, aging
is a major risk factor for glaucoma [1]. Aging of C57BL/6
mice has been reported to alter gene expression profiles and
to be associated with increased oxidative stress in different
ocular  tissues  [56,57]  Therefore,  additional  studies  are
required to also resolve the issue of whether the increased
RGC count observed in the RGS2−/− mice is specific to aging
animals or whether a similar response can be elicited in young
animals as well. Decreased IOP in glaucoma patients has been
shown to protect ganglion cells, contributing to their survival
[58]. However, it is also important to be aware that one cannot
rule  out  the  direct  influence  of  Gαq/RGS2  signaling  on
ganglion cell survival, independent of the effects on IOP.
Indeed, the Gαq-coupled M1 muscarinic receptors and their
agonists have been shown to increase retinal ganglion cell
survival [59]. In contrast to central retina, the retinal ganglion
cell count in the peripheral retina was found to be unaltered
in RGS2−/− mice and the reasons for this difference between
these two regions of the retina is not clear at present. Although
we  cannot  completely  rule  out  the  possibility  of  any
developmental changes in the retina of RGS2−/− mouse, based
on  histological  examination  of  the  retina  in  these  mice
compared to wild-type mice, we did not notice any distinction
between  these  two  groups  of  mice.  Additionally,  in  the
published work, although these mice have been shown to
exhibit abnormalities in T-cell activation, anxiety, aggression,
and  blood  pressure,  there  are  no  known  developmental
changes associated with the deficiency of RGS2 [13].
In  conclusion,  this  pilot  study  reveals  the  potential
importance of RGS2, a negative regulator of Gαq-coupled
GPCR  signaling,  in  IOP  homeostasis.  Decreased  IOP,
together with the morphological changes noted in the SC and
the increased actin filament staining in the CM of RGS2-
deficient  mice,  indicates  a  critical  role  for  Gαq-mediated
signaling in the regulation of contractile activity of the CM
and TM, thereby influencing IOP homeostasis.
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